RxDoctor Payments DataLook up a doctor →

Yair Kissin, MD

Orthopaedic Surgery · Hackensack, NJNPI 1619182276

Payments from drug & device makers

$322,386in general payments, 2019–2025

Across 235 payments — averaging $1371.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Think Surgical, Inc.$298K
  • Techmah Medical, LLC$9K
  • Encore Medical, LP$4K
  • KCI USA, Inc.$3K
  • Zimmer Biomet$2K
  • Pacira Pharmaceuticals Incorporated$2K
  • plus $6K from 31 others
$17,523in research payments, 2019–2025

Across 2 payments — averaging $8761.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Episurf Medical, Inc.$18K

What the payments were for

  • Consulting fees$120,34569%
  • Speaking & faculty fees$2,5001%
  • Travel & lodging$41,81624%
  • Food & beverage$10,3086%
  • Education$3270%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$322,386 in reported general payments places this provider in the 95th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$245,336
Medicare patients
441
Services billed
2,204

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium83$3,173
Meloxicam66$383
Amoxicillin49$125
Gabapentin12$90
Celecoxib12$87

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Hackensack

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →